National regulatory authorities and national ethics committees from across Africa have agreed to
combine their expertise to expedite clinical trial review and approvals for new multinational
preventive, diagnostic and therapeutic interventions to the COVID-19 pandemic.
Proposed new timelines will be 10 days for repurposed therapeutics and 15 days for novel drugs
and vaccines. Find more information here:
WHO- AFRO conducted a survey to map current resources and processes for protocol submission and
approval across member states.
African Academy of Sciences’ Biospecimens and Data Governance Committee Statement On COVID-19:
Ethics, Governance and Community engagement in times of crises.